The artificial promoters showed significantly higher cancer cell specificity compared to E2F1, hTERT, and ARF promoters, indicating that, by artificially modifying tumor suppressor gene promoters, we can enhance cancer cell-specific gene expression. The gene discussed is CDKN2A; the disease is neoplasm.